Justin Briggs
InvestorPartner at Prime Movers Lab · Board director at Zafrens · Board director at Morphoceuticals · Board director at Lygenesis
Oklahoma City, Oklahoma
Writes $2M – $30M checks · typically $5M
Find your path to Justin
219 people in our graph share verified history with Justin — schools, employers, funds. One of them is your warm intro.
About
Justin Briggs is a biochemist and drug developer turned investor who has worked in deep technology commercialization for roughly 18 years. He developed medicines from the bench through clinical trials across small molecules, antibodies, oligos, and vectored vaccines in ten regulatory jurisdictions and four continents, and has been a founder, investor, advisor, or team member for more than thirty biotech, deeptech, nanotech, robotics, and software companies. As an investor he led over $80 million in investments, deployed over $270 million in capital, and served on or observed more than a dozen boards. He currently serves as Head of Corporate Development at Zafrens and Operating Partner at Prime Movers Lab, having previously founded TomorrowScale Ventures and worked with Deep Science Ventures, Antiverse, Tetherex Pharma, and Accele BioPharma.
Contact· published on Justin's own website
Beyond investing
- Founded
- Founded TomorrowScale Ventures, a seed-stage venture firm, in 2019. Founded SnapLap Technologies, a lab automation and machine vision AI company for energy exploration and mineral analysis. Founded Chorus Labs, a productivity software company that was acquired in 2015.
- Awards
- Is an inventor and author on multiple patents and peer-reviewed publications.
From Justin's own website — common ground for a warm intro.
Board director at Zafrens
Intro paths
In turn, Justin can intro founders to Zafrens's investors below.
Zafrens's investors · 9
Co-founders at Zafrens
Board director at Morphoceuticals
Intro paths
In turn, Justin can intro founders to Morphoceuticals's investors below.
Morphoceuticals's investors · 1
Board director at Lygenesis
Intro paths
In turn, Justin can intro founders to Lygenesis's investors below.
Lygenesis's investors · 2
Co-founders at Lygenesis
Experience
- Tulsa Local Ventures + George Kaiser Family FoundationStrategic Advisorcurrent2025 — presentTulsa, Oklahoma, United States
- Prime Movers LabOperating Partnercurrent2024 — presentUnited States
- Prime Movers LabPartner2022 — 2024Pale Blue Dot
- Prime Movers LabVenture Partner2022Pale Blue Dot
- BioeutecticsBoard Membercurrent2025 — presentTulsa, Oklahoma, United States
- ByBugBoard Membercurrent2025 — presentTulsa, Oklahoma, United States
- CASSIE, Inc.Board Membercurrent2025 — presentTulsa, Oklahoma, United States
- VoltBoard Observercurrent2025 — presentTulsa, Oklahoma, United States
- LyGenesisBoard Membercurrent2023 — presentPittsburgh, Pennsylvania, United States
- Morphoceuticals, Inc.Board Membercurrent2023 — presentMedford, Massachusetts, United States
- Iridia, Inc.Board Membercurrent2023 — presentSan Diego, California, United States
- ZafrensVP Corporate Development2024 — 2025San Diego, California, United States
- ZafrensBoard Member2023 — 2024San Diego, California, United States
- Atento CapitalVenture Partner2022 — 2024Tulsa, OK
- Gilgamesh PharmaceuticalsBoard Member2023 — 2024New York, New York, United States
- IVIVA Medical IncBoard Member2023 — 2024Boston, Massachusetts, United States
- Dimension InxBoard Observer2023 — 2024
- Elevian, Inc.Board Member2022 — 2024Boston, Massachusetts, United States
- AntiversePortfolio Director2022United Kingdom
- AntiverseAdvisor2021 — 2022United Kingdom
- TomorrowScale VenturesGeneral Partner2021 — 2022United States
- TomorrowScaleFounder & Host2019 — 2022United States
- Tetherex PharmaceuticalsSenior Director, Drug Development2018 — 2022Oklahoma City, Oklahoma
- Deep Science VenturesVenture Partner2021Global
Skills & more
- Regulatory Affairs Certification (RAC)
From Justin's professional profile.
Investments
Board seats
Dimension InxElevianGilgamesh PharmaceuticalIridiaIviva MedicalLygenesisMorphoceuticalsZafrens
Per the investor's own website.
Colleagues at Prime Movers Lab
Frequently asked questions
- Who is Justin Briggs?
- Justin Briggs is a biochemist and drug developer turned investor who has worked in deep technology commercialization for roughly 18 years. He developed medicines from the bench through clinical trials across small molecules, antibodies, oligos, and vectored vaccines in ten regulatory jurisdictions and four continents, and has been a founder, investor, advisor, or team member for more than thirty biotech, deeptech, nanotech, robotics, and software companies. As an investor he led over $80 million in investments, deployed over $270 million in capital, and served on or observed more than a dozen boards. He currently serves as Head of Corporate Development at Zafrens and Operating Partner at Prime Movers Lab, having previously founded TomorrowScale Ventures and worked with Deep Science Ventures, Antiverse, Tetherex Pharma, and Accele BioPharma.
- Where does Justin Briggs work?
- Justin Briggs is Partner at Prime Movers Lab and Board director at Morphoceuticals and Board director at Lygenesis.
- What check size does Justin Briggs write?
- Justin Briggs typically writes checks of $2M – $30M.
- What boards does Justin Briggs sit on?
- Justin Briggs holds tracked board seats at Dimension Inx, Elevian, Gilgamesh Pharmaceutical, Iridia, Iviva Medical, Lygenesis, Morphoceuticals, Zafrens.
- Where did Justin Briggs go to school?
- Justin Briggs studied at University of Oklahoma (Bachelor of Science (B.Sc.), Biomedical Sciences, Zoology, Business); Oklahoma City University (MBA, Business Administration).
- What awards has Justin Briggs received?
- Is an inventor and author on multiple patents and peer-reviewed publications.
Same school
Also attended University of Oklahoma106
+ 100 more
Also attended Oklahoma City University6
Shared employers
Also worked at LyGenesis2
Also worked at IVIVA Medical Inc1
Also worked at Dimension Inx7
+ 1 more
